Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care

Human thioredoxin (TRX) is a 12-kDa protein with redox-active dithiol in the active site -Cys-Gly-Pro-Cys-, which is induced by biological stress due to oxidative damage, metabolic dysfunction, chemicals, infection/inflammation, irradiation, or hypoxia/ischemia-reperfusion. Our research has demonstrated that exogenous TRX is effective in a wide variety of inflammatory diseases, including viral pneumonia, acute lung injury, gastric injury, and dermatitis, as well as in the prevention and amelioration of food allergies. Preclinical and clinical studies using recombinant TRX (rhTRX) are now underway. We have also identified substances that induce the expression of TRX in the body, in vegetables and other plant ingredients. Skincare products are being developed that take advantage of the anti-inflammatory and anti-allergic action of TRX. Furthermore, we are currently engaged in the highly efficient production of pure rhTRX in several plants, such as lettuce, grain and rice.

[1]  É. Csősz,et al.  Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers , 2017, PloS one.

[2]  E. Larsson,et al.  Thioredoxin a novel biomarker of post‐injury sepsis , 2017, Free radical biology & medicine.

[3]  J. Stamler,et al.  Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. , 2016, The Journal of clinical investigation.

[4]  Lin Qun,et al.  Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. , 2016 .

[5]  Chuan Lu,et al.  Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage , 2016, Journal of the Neurological Sciences.

[6]  H. Masutani,et al.  Thiol redox barrier; local and systemic surveillance against stress and inflammatory diseases. , 2016, Archives of biochemistry and biophysics.

[7]  J. Egido,et al.  Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis. , 2015, Free radical biology & medicine.

[8]  W. Lau,et al.  Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma , 2015, Oncotarget.

[9]  N. Fujii,et al.  Redox proteins are constitutively secreted by skeletal muscle , 2014, The Journal of Physiological Sciences.

[10]  H. Masutani,et al.  Protective effects of oral administration of yeast thioredoxin against gastric mucosal injury , 2014, Bioscience, biotechnology, and biochemistry.

[11]  T. Simmet,et al.  The thioredoxin system as a therapeutic target in human health and disease. , 2013, Antioxidants & redox signaling.

[12]  J. Yodoi,et al.  Thioredoxin Ameliorates Cutaneous Inflammation by Regulating the Epithelial Production and Release of Pro-Inflammatory Cytokines , 2013, Front. Immunol..

[13]  J. Yodoi,et al.  Extracellular thioredoxin: a therapeutic tool to combat inflammation. , 2013, Cytokine & growth factor reviews.

[14]  A. Shaywitz,et al.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. , 2013, Molecular cell.

[15]  Min Liu,et al.  Molecular characterization of differentially expressed TXNIP gene and its association with porcine carcass traits , 2012, Molecular Biology Reports.

[16]  J. Yodoi,et al.  Suppressive effect of recombinant human thioredoxin on ultraviolet light‐induced inflammation and apoptosis in murine skin , 2012, The Journal of dermatology.

[17]  J. Yodoi,et al.  Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin , 2012, Journal of Gastroenterology.

[18]  H. Masutani,et al.  Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus , 2011, Journal of clinical biochemistry and nutrition.

[19]  D. Atlas,et al.  Alleviation of oxidative stress by potent and selective thioredoxin-mimetic peptides. , 2011, Free radical biology & medicine.

[20]  M. Tamoi,et al.  Production of biologically active human thioredoxin 1 protein in lettuce chloroplasts , 2011, Plant Molecular Biology.

[21]  H. Masutani,et al.  Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation , 2010, Leukemia.

[22]  H. Masutani,et al.  Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity , 2010, Nature communications.

[23]  H. Masutani,et al.  Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells. , 2010, Immunology letters.

[24]  A. Holmgren,et al.  Thioredoxin and thioredoxin reductase: current research with special reference to human disease. , 2010, Biochemical and biophysical research communications.

[25]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[26]  Richard T. Lee,et al.  Thioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins* , 2009, The Journal of Biological Chemistry.

[27]  J. Yodoi,et al.  Thioredoxin 1 delivery as new therapeutics. , 2009, Advanced drug delivery reviews.

[28]  J. Yodoi,et al.  Thioredoxin suppresses the contact hypersensitivity response by inhibiting leukocyte recruitment during the elicitation phase. , 2009, Antioxidants & redox signaling.

[29]  H. Masutani,et al.  Fragrant unsaturated aldehydes elicit activation of the Keap1/Nrf2 system leading to the upregulation of thioredoxin expression and protection against oxidative stress. , 2009, Antioxidants & redox signaling.

[30]  H. Masutani,et al.  Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. , 2009, Endocrinology.

[31]  T. Iwanaga,et al.  Correlation of decreased survival and IL-18 in bone metastasis. , 2009, Internal medicine.

[32]  C. E. Alvarez.  On the origins of arrestin and rhodopsin , 2008, BMC Evolutionary Biology.

[33]  S. Werner,et al.  Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.

[34]  S. Fukuhara,et al.  Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. , 2008, Antioxidants & redox signaling.

[35]  L. Sui,et al.  Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1. , 2008, International journal of oncology.

[36]  P. Emery,et al.  TRPC channel activation by extracellular thioredoxin , 2008, Nature.

[37]  Seiji Kawano,et al.  Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. , 2007, The Journal of rheumatology.

[38]  Y. Ishii,et al.  Lipid raft-mediated uptake of cysteine-modified thioredoxin-1: apoptosis enhancement by inhibiting the endogenous thioredoxin-1. , 2007, Antioxidants & redox signaling.

[39]  M. Gutscher,et al.  Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1 , 2007, The EMBO journal.

[40]  H. Matsui,et al.  Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice , 2007, Free radical research.

[41]  A. Holmgren,et al.  Thioredoxin and related molecules--from biology to health and disease. , 2007, Antioxidants & redox signaling.

[42]  M. Mishima,et al.  Elevation of serum thioredoxin in patients with gefitinib-induced interstitial lung disease. , 2007, Internal medicine.

[43]  H. Masutani,et al.  Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. , 2006, Seminars in cancer biology.

[44]  Y. Ishii,et al.  Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. , 2006, Gastroenterology.

[45]  H. Masutani,et al.  Redox regulation of human thioredoxin network. , 2006, Antioxidants & redox signaling.

[46]  Richard T. Lee,et al.  The Interaction of Thioredoxin with Txnip , 2006, Journal of Biological Chemistry.

[47]  A. Nicholson,et al.  Extracellular thioredoxin levels are increased in patients with acute lung injury , 2006, Thorax.

[48]  J. Yodoi,et al.  Clinical Significance of Serum Thioredoxin 1 Levels in Patients with Acute Pancreatitis , 2006, Pancreas.

[49]  C. Distelhorst,et al.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis , 2006, Oncogene.

[50]  H. Masutani,et al.  Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling. , 2006, Endocrinology.

[51]  Y. Ishii,et al.  Redox regulation of mast cell histamine release in thioredoxin-1 (TRX) transgenic mice , 2006, Cell Research.

[52]  H. Hirata,et al.  Impaired fatty acid utilization in thioredoxin binding protein‐2 (TBP‐2)‐deficient mice: a unique animal model of Reye syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  J. Yodoi,et al.  Increased plasma levels of thioredoxin in patients with glucose intolerance. , 2005, Internal medicine.

[54]  J. Yodoi,et al.  Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1 , 2005, Laboratory Investigation.

[55]  M. Callister,et al.  Thioredoxin: friend or foe in human disease? , 2005, Trends in pharmacological sciences.

[56]  S. Rhee,et al.  Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. , 2005, Free radical biology & medicine.

[57]  Chae Young Hwang,et al.  Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. , 2005, Cancer research.

[58]  H. Masutani,et al.  The thioredoxin system in retroviral infection and apoptosis , 2005, Cell Death and Differentiation.

[59]  J. Yodoi,et al.  Plasma thioredoxin levels in patients with unstable angina. , 2005, International journal of cardiology.

[60]  M. Tanito,et al.  Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. , 2005, Investigative ophthalmology & visual science.

[61]  U. Dahlström,et al.  Elevated circulating levels of thioredoxin and stress in chronic heart failure , 2004, European journal of heart failure.

[62]  Y. Ishii,et al.  Importin α1 (Rch1) Mediates Nuclear Translocation of Thioredoxin-binding Protein-2/Vitamin D3-up-regulated Protein 1* , 2004, Journal of Biological Chemistry.

[63]  A. Lusis,et al.  Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice. , 2004, The Journal of nutrition.

[64]  J. Yodoi,et al.  Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. , 2003, American heart journal.

[65]  J. Yodoi,et al.  Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. , 2003, Immunology letters.

[66]  Norihiko Kondo,et al.  Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response , 2003, Oncogene.

[67]  H. Masutani,et al.  Critical Roles of Thioredoxin in Nerve Growth Factor-Mediated Signal Transduction and Neurite Outgrowth in PC12 Cells , 2003, The Journal of Neuroscience.

[68]  J. Yodoi,et al.  Increased plasma thioredoxin in patients with acute myocardial infarction , 2002, Clinical cardiology.

[69]  M. Gábor.  Models of acute inflammation in the ear. , 2003, Methods in molecular biology.

[70]  J. Yodoi,et al.  Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. , 2003, Journal of hepatology.

[71]  A. Holmgren,et al.  A Novel Antioxidant Mechanism of Ebselen Involving Ebselen Diselenide, a Substrate of Mammalian Thioredoxin and Thioredoxin Reductase* , 2002, The Journal of Biological Chemistry.

[72]  P. Li,et al.  Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1 , 2002, Nature Immunology.

[73]  A. Holmgren,et al.  Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  H. Nakamura,et al.  Elevation of serum thioredoxin levels in patients with type 2 diabetes. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[75]  J. Yodoi,et al.  Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. , 2002, Molecular immunology.

[76]  H. Nakamura,et al.  Redox Regulation of Stress Signals: Possible Roles of Dendritic Stellate TRX Producer Cells (DST Cell Types) , 2002, Biological chemistry.

[77]  P. D. de Jong,et al.  Positional cloning of the combined hyperlipidemia gene Hyplip1 , 2002, Nature genetics.

[78]  H. Masutani,et al.  Hemin-induced Activation of the Thioredoxin Gene by Nrf2 , 2001, The Journal of Biological Chemistry.

[79]  H. Nakamura,et al.  Serum thioredoxin (TRX) levels in patients with heart failure. , 2001, Japanese circulation journal.

[80]  P. Ghezzi,et al.  Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[81]  H. Matsui,et al.  Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes , 2001, Free radical research.

[82]  H. Nakamura,et al.  Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. , 2000, Journal of hepatology.

[83]  H. Nakamura,et al.  Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. , 2000, Biochemical and biophysical research communications.

[84]  T. Horie,et al.  Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation , 2000, Thorax.

[85]  Y. Yamaoka,et al.  Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer. , 2000, Cancer detection and prevention.

[86]  B. Sahaf,et al.  Thioredoxin blood level increases after severe burn injury. , 2000, Antioxidants & redox signaling.

[87]  F. Breedveld,et al.  Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[88]  M. Matsui,et al.  Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression* , 1999, The Journal of Biological Chemistry.

[89]  S. Yoshida,et al.  Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. , 1999, Journal of immunology.

[90]  A. Holmgren,et al.  Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. , 1998, Free radical biology & medicine.

[91]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[92]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[93]  H. Nakamura,et al.  Redox regulation of cellular activation. , 1997, Annual review of immunology.

[94]  H. Masutani,et al.  Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. , 1996, Immunology letters.

[95]  M. Roederer,et al.  Elevation of plasma thioredoxin levels in HIV-infected individuals. , 1996, International immunology.

[96]  H. DeLuca,et al.  Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. , 1994, Biochimica et biophysica acta.

[97]  R. Sitia,et al.  Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. , 1992, The Journal of biological chemistry.

[98]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[99]  J. Yodoi,et al.  Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. , 1992, Nucleic acids research.

[100]  J. Wells,et al.  Isolation and characterization of human thioredoxin-encoding genes. , 1991, Gene.

[101]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[102]  T. Uchiyama.  Adult T-cell leukemia. , 1988, Blood reviews.

[103]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.

[104]  J. Yodoi,et al.  Letter: Two cases of T-cell chronic lymphocytic leukemia in Japan. , 1974, The New England journal of medicine.

[105]  H. Bennich,et al.  Immunological studies of an atypical (myeloma) immunoglobulin. , 1967, Immunology.

[106]  K. Ishizaka,et al.  Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. , 1966, Journal of immunology.

[107]  T. Laurent,et al.  ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. , 1964, The Journal of biological chemistry.